IVDs star in German rare diseases plan, but will commercial benefits match?
This article was originally published in Clinica
After almost three years of interministerial collaboration, Germany’s national action plan for sufferers of rare diseases, NAMSE, has been published and released to the German cabinet.
You may also be interested in...
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The RSNA is the next global medtech exhibition and conference event to be run under a virtual format this fall.
COVID-19 put a dampener on Conmed’s 50th anniversary of operations, but CFO Todd Garner says the company is poised to resume its growth strategy, post-pandemic.